Recent advances in molecular biomarkers for diabetes mellitus: a systematic review.

about

Social jetlag and metabolic control in non-communicable chronic diseases: a study addressing different obesity statuses.

P2860

Q41123367-674C5D70-901F-41E0-8D02-E88E05BB011B

P2860

Recent advances in molecular biomarkers for diabetes mellitus: a systematic review.

Item

http://www.wikidata.org/entity/Q39079275

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Recent advances in molecular biomarkers for diabetes mellitus: a systematic review.

@en

Recent advances in molecular biomarkers for diabetes mellitus: a systematic review.

@nl

type

Item

label

Recent advances in molecular biomarkers for diabetes mellitus: a systematic review.

@en

Recent advances in molecular biomarkers for diabetes mellitus: a systematic review.

@nl

prefLabel

Recent advances in molecular biomarkers for diabetes mellitus: a systematic review.

@en

Recent advances in molecular biomarkers for diabetes mellitus: a systematic review.

@nl

P1476

Recent advances in molecular biomarkers for diabetes mellitus: a systematic review.

@en

P2093

Allan Jones

http://www.w3.org/2001/XMLSchema#string

Ann Simpson

http://www.w3.org/2001/XMLSchema#string

Fatima Shad-Kaneez

http://www.w3.org/2001/XMLSchema#string

Najah Nassif

http://www.w3.org/2001/XMLSchema#string

Xianqin Qu

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

What are biomarkers?

2-Aminoadipic acid is a biomarker for diabetes risk

A microRNA code for prostate cancer metastasis.

Building multidimensional biomarker views of type 2 diabetes on the basis of protein microheterogeneity

The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus

Comprehensive biomarker testing of glycemia, insulin resistance, and beta cell function has greater sensitivity to detect diabetes risk than fasting glucose and HbA1c and is associated with improved glycemic control in clinical practice

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis.

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.

P304

604-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/1354750X.2017.1279216

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ty Lees

Sara Lal

Yiguang Lin

Rosetta Martiniello-Wilks

P577

2017-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28074664

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Recent advances in molecular biomarkers for diabetes mellitus: a systematic review.

about

P2860

P2860

Recent advances in molecular biomarkers for diabetes mellitus: a systematic review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921